Literature DB >> 8423093

Impact of experimental genital mycoplasmosis on pregnancy outcome in Sprague-Dawley rats.

D A Steiner1, M B Brown.   

Abstract

Specific-pathogen-free (SPF) female Sprague-Dawley rats were infected by intravaginal inoculation with 3 x 10(7) CFU of Mycoplasma pulmonis X1048 in 0.1 ml of Frey's broth or with an equal volume of sterile Frey's broth. A minimum of 10 days postinfection, rats were bred to noninfected males. Rats were necropsied at days 11, 14, and 18 of gestation and within 24 h of parturition. Throughout pregnancy, at least 50% of rats remained infected in the lower genital tract. At parturition, the major site of colonization was the respiratory tract (P = 0.02). M. pulmonis was not isolated from any site of any control rat. Pregnancy outcome was adversely affected by infection with M. pulmonis. Infected rats had significantly smaller litter sizes at day 18 of gestation (P < or = 0.01) and at term (P < or = 0.004). No statistically significant differences among the gestational stages in infected rats were noted for litter size. Total litter weight is a reflection of individual pup weight and of the number of pups born. Therefore, it was obvious that infected rats would have a significantly lower (P < or = 0.008) total litter weight than noninfected controls. However, when individual pup weights were considered, infected pups (n = 49) also had significantly lower (P < or = 0.0001) birth weights than did noninfected controls (n = 68). The incidence of an adverse pregnancy outcome at term (stillbirths, macerated fetuses, or resorptions) was higher (P < or = 0.01) in infected rats than in noninfected control rats. No stillborn pups or macerated fetuses were observed in any control term rats (n = 5). All control rats had live-born pups. Three infected rats had no live-born offspring. Resorptions were more common in infected rats than in control rats (P < or = 0.01). The mean number of resorptions per rat was greater in rats which went to term than in rats necropsied during gestation, indicating that the severity of disease was progressive. The rat is frequently the laboratory animal of choice for a wide variety of reproductive studies, and the experimental parameters that are most often measured (litter size, pup weight, and neonatal survival) were all adversely affected by genital mycoplasmosis. Genital mycoplasmosis is important as an animal model for the interaction of infectious agents and the host during pregnancy as well as in its own right as a confounding variable affecting research projects which use the rat as a model to study reproductive function and physiology.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8423093      PMCID: PMC302774          DOI: 10.1128/iai.61.2.633-639.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  18 in total

1.  Nonspecific lymphocyte responses in F344 and LEW rats: susceptibility to murine respiratory mycoplasmosis and examination of cellular basis for strain differences.

Authors:  J K Davis; J W Simecka; J S Williamson; S E Ross; M M Juliana; R B Thorp; G H Cassell
Journal:  Infect Immun       Date:  1985-07       Impact factor: 3.441

2.  Serum antibody does not account for differences in the severity of chronic respiratory disease caused by Mycoplasma pulmonis in LEW and F344 rats.

Authors:  J W Simecka; J K Davis; G H Cassell
Journal:  Infect Immun       Date:  1989-11       Impact factor: 3.441

3.  Natural mycoplasmal infections in isolator-maintained LEW/Tru rats.

Authors:  N R Cox; M K Davidson; J K Davis; J R Lindsey; G H Cassell
Journal:  Lab Anim Sci       Date:  1988-08

4.  Enhancement of experimental Mycoplasma pulmonis infection of the mouse genital tract by progesterone treatment.

Authors:  P M Furr; D Taylor-Robinson
Journal:  J Hyg (Lond)       Date:  1984-04

5.  Respiratory and genital mycoplasmosis of laboratory rodents: implications for biomedical research.

Authors:  G H Cassell; J R Lindsey; J K Davis
Journal:  Isr J Med Sci       Date:  1981-07

6.  Serum antibody and cellular responses in LEW and F344 rats after immunization with Mycoplasma pulmonis antigens.

Authors:  J W Simecka; G H Cassell
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

7.  Postcopulatory genital grooming in male rats: prevention of sexually transmitted infections.

Authors:  B L Hart; E Korinek; P Brennan
Journal:  Physiol Behav       Date:  1987

8.  The interplay of host and organism factors in infection of the mouse genital tract by Mycoplasma pulmonis.

Authors:  D Taylor-Robinson; P M Furr
Journal:  J Hyg (Lond)       Date:  1985-08

Review 9.  Cytokine networks in the uteroplacental unit: macrophages as pivotal regulatory cells.

Authors:  J S Hunt
Journal:  J Reprod Immunol       Date:  1989-09       Impact factor: 4.054

Review 10.  Mycoplasma pulmonis-host relationships in a breeding colony of Sprague-Dawley rats with enzootic murine respiratory mycoplasmosis.

Authors:  J R Lindsey; M K Davidson; T R Schoeb; G H Cassell
Journal:  Lab Anim Sci       Date:  1985-12
View more
  4 in total

1.  Experimental genital mycoplasmosis: time of infection influences pregnancy outcome.

Authors:  M B Brown; D A Steiner
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

2.  In utero transmission of Mycoplasma pulmonis in experimentally infected Sprague-Dawley rats.

Authors:  D A Steiner; E W Uhl; M B Brown
Journal:  Infect Immun       Date:  1993-07       Impact factor: 3.441

3.  Hematogenous infection of Sprague-Dawley rats with Mycoplasma pulmonis: development of a model for maternal and fetal infection.

Authors:  Margaret A Riggs; Fiona P Maunsell; Leticia Reyes; Mary B Brown
Journal:  Am J Obstet Gynecol       Date:  2008-02-20       Impact factor: 8.661

4.  Development of an ELISA using a recombinant P46-like lipoprotein for diagnosis of Mycoplasma pulmonis infection in rodents.

Authors:  Atsushi Asano; Daisuke Torigoe; Nobuya Sasaki; Takashi Agui
Journal:  J Vet Med Sci       Date:  2013-09-20       Impact factor: 1.267

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.